Company intelligence / Profile preview

Wemedoo

Ownership: Private
Development stage: Commercial

Overview

Wemedoo provides interoperable clinical data management solutions through its flagship product oomnia. This unified SaaS platform streamlines all aspects of clinical trial operations—enabling up to 83% faster trial setup compared to major CROs and providing real-time oversight with instant SDTM datasets. It has been adopted by global alliances such as Across Global Alliance for centralized digital infrastructure in over 90 countries[1][2][5][7][8].

Industry: Biomedical IT and Biomedical Data Platforms

Partnerships

Across Global Alliance (strategic partnership for global CRO network infrastructure)

Beyond the preview

Go deeper on Wemedoo.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Wemedoo.

Explore the full profile